Strumeel® forte N

Drops Composition:

Strumeel Tablets: 1 tablet cont.: Spongia D3 150 mg; Calcium jodatum D4 90 mg; Acidum silicicum D4, Fucus vesiculosus D4 30 mg each.

Strumeel forte N Drops: 100 g cont.: Spongia D2 50 g; Calcium jodatum D3 30 g; Acidum silicicum colloidale D8, Fucus vesiculosus D3 10 g each. Contains 40 vol.-% alcohol.


Tablets: Struma parenchymatosa juvenilis; in goitre prophylaxis.

Drops: Struma parenchymatosa (diffusa,); in goitre prophylaxis; arteriosclerosis and other conditions where iodine is indicated.


Hypersensitivity to iodine.

Side effects:

Aggravation of existing hyperthyroidism. Interactions with other medication:

None known.


The dosage must be determined individually.

Strumeel Tablets: In general, 1 tablet to be dissolved under the tongue 3 times daily.

Strumeel forte N Drops: In general, 10 drops 3 times daily.

Package sizes:

Strumeel Tablets: Packs containing 50 and 250 tablets. Strumeel forte N Drops: Drop bottles containing 30 and 100 ml.

Pharmacological and clinical notes

Spongia (roasted sea sponge)

Struma colloides et parenchymatosa, glandular swelling, dry cough similar to croup, myocardial impairment.

Calcium jodatum (calcium iodide)

Struma, tonsillar hypertrophy, scrofulous glands. Silicea (silica)

Weakness of the connective tissue and constitutional weakness; rachitic, dystrophic, exudative and scrofulous children; lymphatism.

Fucus vesiculosus (bladder-wrack)

Scrofulous glandular swelling, struma, adiposis.

Based on the individual homoeopathic constituents of Strumeel, possibilities result for iodine therapy in cases of struma parenchymatosa et colloides (Strumeel forte N drops), goitre prophylaxis (Strumeel tablets); arteriosclerosis, coronary sclerosis; auxiliary remedy for aortic aneurysm (in addition to Kalmia-Injeel forte S, Barijodeel, Mercurius jodatus flavus-Injeel, etc.); hypertonia, adiposis, scrofulous glandular swellings and reticulosis (Galium-Heel, Lymphomyosot, Psorinoheel, Traumeel S,  etc.); croupal coughs (Husteel, Aconitum-Homaccord).

Based on the organic bonding of the iodine, toxic phenomena or hypersensitive reactions virtually do not occur, and in spite of intense application, including in massive initial-dose therapy, have not yet been observed in the widest variety of phases.

The dosage is adjusted according to the disease, the symptoms and the stage of the illness: 1 tablet 2-5 times daily up to 2 tablets 3 times daily, or 5 drops twice daily (prophylactic dose), or 10-20 drops 3 times daily (therapeutic dose). For school children, as goitre prophylaxis: 1 tablet once to twice daily. The dosage must be decided individually.